TCS, HDFCBANK, SBI Liquid Fund (G)
Medicamen Biotech Ltd.
Medicamen Biotech
NSE
₹ 0.00
0.00 (0.00)%
Healthcare
Small-cap
With a market cap of ₹18.90L Cr.
Moderate Volatility
Stock is 1.13x as volatile as index
| EX-Date | Purpose |
|---|---|
| 26 06 2021 | Audited Results |
| 13 08 2021 | Quarterly Results |
| 03 11 2021 | Quarterly Results |
| 08 02 2022 | Quarterly Results |
| 25 05 2022 | Final Dividend & Audited Results |
| 01 08 2022 | Preferential Issue of shares |
| 10 08 2022 | Quarterly Results |
| 11 11 2022 | Quarterly Results |
| 10 02 2023 | Quarterly Results |
| 29 05 2023 | Final Dividend & Audited Results |
| 08 08 2023 | Quarterly Results |
| 10 11 2023 | Quarterly Results |
| 12 02 2024 | Quarterly Results |
| 14 11 2024 | Quarterly Results |
| 11 02 2025 | Quarterly Results |
| 26 02 2025 | Preferential Issue of shares & Inter alia, to consider and approve a proposal for raising of funds by way of issuance of one or more instruments including equity shares/convertible securities either by way of Preferential Issue/Right Issue/QIP or any other mode. |
News
No News data available
